Lung Disease Therapeutics Market to Hit USD 163.1B by 2033
OverviewThe Global Lung Disease Therapeutics Market has been projected to reach USD 163.1 billion by 2033. It was valued at...
OverviewThe Global Lung Disease Therapeutics Market has been projected to reach USD 163.1 billion by 2033. It was valued at...
Connecticut is the second-best state in the country for lung cancer survival and screening, but the American Lung Association in...
The link between air pollution and lung cancer is no longer speculative; it is scientifically proven and deeply concerning. Fine...
Wearable devices and hospital monitors may dominate conversations about remote health care, but a new Cornell-affiliated startup is betting its...
While other organized screening programs are well-established, organized lung cancer screening remains less familiar to many Canadians, yet it’s a...
Recent advancements in cancer treatment are poised to redefine patient care paradigms globally, particularly in emerging markets like China. A...
Chris Wood, CEO of Reveal Dx With lung cancer being the leading cause of cancer-related deaths worldwide, advancements in AI-powered...
MISSISSAUGA, ON, Oct. 21, 2025 /CNW/ – Dalhousie University, in collaboration with Nova Scotia Health’s INSPIRED COPD Outreach Program, the Nova...
A new digital health tool increased rates of lung cancer screening, according to research published Oct. 20 in JAMA. Investigators...